Showing results (1311-1320 of 1,492) with videos related to
Sort By:
Pageof 150
The Oncologist|April 8, 2021
Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II StudyYe Chen, Yu-Wen Zhou, Ke Cheng, et al.Acta Pharmacologica Sinica|September 13, 2011
Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbitsYa-Pei Yang, Qiu-Li Dong, Xu-Hong Zhang, et al.Cell Death and Differentiation|January 12, 2021
Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2Xiang Luo, Hai-Biao Gong, Hua-Ying Gao, et al.Frontiers in Immunology|June 25, 2024
Long-term outcomes and predictive factors of achieving low disease activity status in childhood systemic lupus erythematosus: a Chinese bicentric retrospective registered studyXi Xi Yu, Jia Deng, Qiu Xia Chen, et al.Cell Death & Disease|September 24, 2021
SAP130 released by damaged tubule drives necroinflammation via miRNA-219c/Mincle signaling in acute kidney injuryLin-Li Lv, Cui Wang, Zuo-Lin Li, et al.Journal of Ovarian Research|October 12, 2019
LncRNA AB209371 up-regulated Survivin gene by down-regulating miR-203 in ovarian carcinomaZi-Hui Zheng, Dong-Mei Wu, Shao-Hua Fan, et al.Ecotoxicology and Environmental Safety|April 30, 2022
Stimulating the expression of sphingosine kinase 1 (SphK1) is beneficial to reduce acrylamide-induced nerve cell damageCui-Ping Yu, Yu-Lin Pan, Xiao-Li Wang, et al.Cancer Investigation|June 14, 2013
Clinical characteristics of patients with solitary pulmonary mass after radical treatment for primary cancers: pulmonary metastasis or second primary lung cancer?Jun Ge, Hong-Feng Gou, Ye Chen, et al.Journal of Medicinal Chemistry|March 25, 2022
Structure-Based Discovery and Optimization of Furo[3,2-c]pyridin-4(5H)-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) InhibitorsJunhua Li, Cheng Zhang, Hongrui Xu, et al.Cell Death & Disease|May 24, 2023
Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagyZuo-Lin Li, Lin Ding, Rui-Xia Ma, et al.Pageof 150